- Current report filing (8-K)
October 13 2009 - 9:25AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported)
October 9,
2009
deCODE genetics, Inc.
(Exact Name of Registrant as
Specified in Charter)
Delaware
|
|
000-30469
|
|
04-3326704
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
Sturlugata 8, IS-101 Reykjavik,
Iceland
(Address of Principal Executive Offices)
Registrants telephone number, including area code
+354-570-1900
(Former Name or Former
Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
Item
1.01.
Entry
into A Material Definitive Agreement
(a)
Effective October 9,
2009, the secured promissory note dated September 11, 2009, among deCODE
genetics, Inc., MediChem Life Sciences, Inc., deCODE Biostructures, Inc.
and Saga Investments LLC, as amended on September 25, 2009 and October 1,
2009, was further amended to provide that the maturity date thereunder is October 19,
2009.
Item 2.03.
Creation
of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.
The information set forth in Item 1.01 of this Current Report on Form 8-K
is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
deCODE
genetics, Inc.
|
|
|
|
|
|
By:
|
/s/
KARI STEFANSSON
|
|
|
Kari
Stefansson
|
|
|
President and Chief Executive Officer
|
Dated: October 13, 2009
3
Decode Genetics (MM) (NASDAQ:DCGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Decode Genetics (MM) (NASDAQ:DCGN)
Historical Stock Chart
From Jul 2023 to Jul 2024